Skip to main content
Retour
Watch Compare

Healthcare Triangle, Inc.

Qualité des données : 100%
HCTI
NASDAQ Services Business Services
2,45 €
▼ 0,08 € (-3,16%)
6 months return
—
Momentum
Neutral
ROE
-66,77%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-64,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-66,77%
En dessous de la moyenne du secteur (-15,99%)
ROIC-39,66%
Net Margin-48,84%
Op. Margin-45,16%

Sécurité

Debt / Equity
0,18
En dessous de la moyenne du secteur (0,39)
Current Ratio2,03
Interest Coverage-15,14

Valorisation

PE (TTM|NTM)
-0,44 | -0,19
Au-dessus de la moyenne du secteur (-1,18)
P/B Ratio0,32
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 0,18 — conservative balance sheet
Negative free cash flow of -10,51 M
Capital efficient — spends only 0,08% of revenue on capex

Price History

Tendances Financières

Objectif de Cours des Analystes

1 analyste
Hold
+12144.9%
upside to target
Actuel
2,45 €
Consensus Target
300,00 €
300,00 €
Bas
300,00 €
Haut
Prévisions
P/E Prévisionnel
-0,19
BPA Prévisionnel
-13,20 €
CA Est.
29,31 M

Surprises de Résultats

EPS
Reported Estimate
Q22025 Q32025 Q42025
Reported -34,80 € -25,20 € —
Estimate — -13,20 € -12,00 €
Surprise — -90,91% —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) -64,77% Revenue Growth (3Y) -49,51%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -66,77% · Net Margin: -48,84%
Revenue (TTM) 12,94 M Net Income (TTM) -6,32 M
ROE -66,77% ROA -44,50%
Gross Margin 8267,66% Operating Margin -45,16%
Net Margin -48,84% Free Cash Flow (TTM) -10,51 M
ROIC -39,66% FCF Growth (3Y) N/A

Safety

D/E: 0,18 · Current: 2,03
Debt / Equity 0,18 Current Ratio 2,03
Interest Coverage -15,14 Asset Turnover 0,91
Working Capital 4,03 M Tangible Book Value 8,54 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,44 · EV/EBITDA: N/A
P/E Ratio -0,44 Forward P/E -0,19
P/B Ratio 0,32 P/S Ratio 0,21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,09 Fwd Earnings Yield N/A
FCF Yield -379,06%
Market Cap 2,77 M Enterprise Value 2,67 M

Per Share

EPS: -2,46 · FCF/Share: -9,10
EPS (Diluted TTM) -2,46 Revenue / Share 11,20
FCF / Share -9,10 OCF / Share -9,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 166,29% · CapEx/Rev: 0,08%
CapEx / Revenue 0,08% FCF Conversion 166,29%
SBC-Adj. FCF -10,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue 11,70 M 33,20 M 45,89 M 35,27 M
Net Income -5,97 M -12,34 M -9,61 M -5,95 M
EPS (Diluted) -1,13 -2,92 — -0,20
Gross Profit 1,07 B 1,07 B — —
Operating Income -4,75 M -11,35 M -10,42 M -5,36 M
EBITDA — — — —
R&D Expenses 429 000,0 799 000,0 5,95 M 5,26 M
SG&A Expenses — — 0,0 —
D&A 889 000,0 7,23 M 3,37 M 1,42 M
Interest Expense -1,21 M 968 000,0 212 000,0 566 735,0
Income Tax 12 000,0 35 000,0 63 000,0 24 246,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 1,96 M 10,05 M 20,76 M 24,61 M
Total Liabilities 7,08 M 9,51 M 8,38 M 8,48 M
Shareholders' Equity -5,11 M 538 000,0 12,48 M 16,13 M
Total Debt 2,65 M 3,43 M 2,41 M 2,21 M
Cash & Equivalents 20 000,0 1,23 M 1,34 M 1,77 M
Current Assets 1,45 M 5,73 M 7,75 M 11,80 M
Current Liabilities 7,08 M 8,12 M 6,15 M 6,25 M

Comparaison Sectorielle

vs médiane du secteur Services (615 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,2
P/B 0,3 1,4
ROE % -66,8 -16,0
Net Margin % -48,8 -18,7
Rev Growth 5Y % — 4,0
D/E 0,2 0,4